{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T06:55:56Z","timestamp":1770533756157,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006680","name":"Takeda Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006680","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007077","name":"National Institute of Biomedical Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.cca.2011.09.013","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T10:21:03Z","timestamp":1316514063000},"page":"160-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Establishment of chemiluminescence enzyme immunoassay for apolipoprotein B-48 and its clinical applications for evaluation of impaired chylomicron remnant metabolism"],"prefix":"10.1016","volume":"413","author":[{"given":"Hiroyuki","family":"Hanada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Mugii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuhiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Kuwayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoh","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Kitazume-Taneike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiji","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Nakaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwako","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyako","family":"Yuasa-Kawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Tsubakio-Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisaku","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Ohama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2011.09.013_bb0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.60.3.473","article-title":"Atherogenesis: a postprandial phenomenon","volume":"60","author":"Zilversmit","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2011.09.013_bb0010","doi-asserted-by":"crossref","first-page":"D332","DOI":"10.2741\/Yu","article-title":"Postprandial lipoproteins and atherosclerosis","volume":"6","author":"Yu","year":"2001","journal-title":"Front Biosci"},{"key":"10.1016\/j.cca.2011.09.013_bb0015","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0022-2275(20)37199-6","article-title":"A single copy of apolipoprotein B-48 is present on the human chylomicron remnant","volume":"38","author":"Phillips","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2011.09.013_bb0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1098-2825(1998)12:5<289::AID-JCLA7>3.0.CO;2-1","article-title":"Establishment of monoclonal antibody against human ApoB-48 and measurement of ApoB-48 in serum by ELISA method","volume":"12","author":"Uchida","year":"1998","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.cca.2011.09.013_bb0025","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1194\/jlr.M300090-JLR200","article-title":"Measurement of fasting serum apoB-48 concentrations in normolipidemic and hyperlipidemic subjects by ELISA","volume":"44","author":"Sakai","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2011.09.013_bb0030","unstructured":"NCCLS. Protocols for determination of limits of detection; approved guideline 2004. NCCLS document EP17-A (ISBN 1-56238-551-8)."},{"key":"10.1016\/j.cca.2011.09.013_bb0035","first-page":"794","article-title":"Definition and diagnostic norm of metabolic syndrome","volume":"94","author":"Metabolic Syndrome Diagnosis Standard Advisory Committe","year":"2005","journal-title":"JJSIM"},{"key":"10.1016\/j.cca.2011.09.013_bb0040","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/S0022-2275(20)41487-7","article-title":"Increased proportion of plasma apoB-48 to apoB-100 in non-insulin-dependent diabetic rats: contribution of enhanced apoB mRNA editing in the liver","volume":"36","author":"Yamane","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2011.09.013_bb0045","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1194\/jlr.P700032-JLR200","article-title":"Chylomicron remnants are increased in the postprandial state in CD36 deficiency","volume":"50","author":"Masuda","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2011.09.013_bb0050","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.diabres.2008.04.028","article-title":"Association of serum apolipoprotein B48 concentration with the presence of carotid plaque in type 2 diabetes mellitus","volume":"81","author":"Tanimura","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.cca.2011.09.013_bb0055","first-page":"1058","article-title":"Clinical significance of apolipoprotein B-48 (apoB-48) in patients with thyroid disease","volume":"57","author":"Mugii","year":"2009","journal-title":"Rinsho Byori"},{"key":"10.1016\/j.cca.2011.09.013_bb0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0021-9150(96)05832-7","article-title":"Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case\u2013control study","volume":"124","author":"Meyer","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.09.013_bb0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0021-9150(90)90111-U","article-title":"Postprandial lipemia, fenofibrate and coronary artery disease","volume":"85","author":"Simpson","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.09.013_bb0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0021-9150(94)90085-X","article-title":"Postprandial lipoproteins and progression of coronary atherosclerosis","volume":"106","author":"Karpe","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.09.013_bb0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/vhrm.2006.2.2.145","article-title":"Metabolic syndrome, inflammation and atherosclerosis","volume":"2","author":"Daoletti","year":"2006","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.cca.2011.09.013_bb0080","first-page":"149","article-title":"Metabolic syndrome: overview","volume":"33","author":"Yamada","year":"2008","journal-title":"JJCLA"},{"key":"10.1016\/j.cca.2011.09.013_bb0085","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","article-title":"Plasma adiponectin concentrations and risk of myocardial infarction in men","volume":"291","author":"Pischon","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2011.09.013_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5551\/jat.E598","article-title":"Remnant lipoproteins as strong key particles to atherogenesis","volume":"16","author":"Fujioka","year":"2009","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"10.1016\/j.cca.2011.09.013_bb0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2011.05.009","article-title":"Serum apolipoprotein B-48 concentrations are correlated with carotid intima-media thickness in subjects with normal serum triglyceride concentrations","volume":"218","author":"Nakatani","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.09.013_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-2001-12397","article-title":"Stimulation of arterial smooth muscle cell proliferation by remnant lipoprotein particles isolated by immuno-affinity chromatography with anti-apo A-I and anti-apo B-100","volume":"33","author":"Kawakami","year":"2001","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.cca.2011.09.013_bb0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0009-8981(93)90062-9","article-title":"Cholesterol in remnant-like particles in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gel","volume":"223","author":"Nakajima","year":"1993","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2011.09.013_bb0120","first-page":"528","article-title":"Fundamental evaluation of apolipoprotein B-48 by chemiluminescence enzyme immunoassay\u2014identification of apolipoprotein B-48 with immunoblotting","volume":"55","author":"Sato","year":"2007","journal-title":"Rinsho Byori"},{"key":"10.1016\/j.cca.2011.09.013_bb0115","first-page":"203","article-title":"Postprandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state","volume":"29","author":"Smith","year":"1999","journal-title":"Eur J Cli Invest"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111004992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111004992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:00:50Z","timestamp":1762113650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898111004992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":23,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0009898111004992"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2011.09.013","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of chemiluminescence enzyme immunoassay for apolipoprotein B-48 and its clinical applications for evaluation of impaired chylomicron remnant metabolism","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2011.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}